Pharma

PharmaMar

My videos
Taofeek Owonikoko MD, PhD, MSCR - Lurbinectedin, a potential practice changing drug if approved
0:02:13

Taofeek Owonikoko MD, PhD, MSCR - Lurbinectedin, a potential practice changing drug if approved
Small Cell Lung Cancer Free HD
72 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Hossein Borghaei, DO, MS - New Drug Application (NDA) for lurbinectedin
0:07:54

Hossein Borghaei, DO, MS - New Drug Application (NDA) for lurbinectedin
Small Cell Lung Cancer Free HD
72 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Spanish Version - Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial
00:29:12

Spanish Version - Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial
Small Cell Lung Cancer Free HD
488 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial
00:28:53

Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial
Small Cell Lung Cancer Free HD
893 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Luis G. Paz-Ares, MD, PHD Special Presentation June 1st, 2019 McCormick Place Hall D2, 3pm
00:00:28

Luis G. Paz-Ares, MD, PHD Special Presentation June 1st, 2019 McCormick Place Hall D2, 3pm
Small Cell Lung Cancer Free HD
585 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Loading